Uganda begins trial of HIV preventive vaccine in Masaka
Uganda has started an efficacy trial of an HIV vaccine for the purposes of testing if it can prevent HIV infection. The vaccine known as PrepVacc is a phase 3 trial using a combination of two drugs meant to test two ways of preventing HIV in a human body. According to the Uganda Virus Research Institute, which is leading the trials, the process started on Tuesday at their site in Masaka.